Loomis, Sayles & Company’s Insmed INSM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $79.9M | Sell |
793,569
-215,897
| -21% | -$21.7M | 0.1% | 72 |
|
|
2025
Q1 | $77M | Sell |
1,009,466
-165,325
| -14% | -$12.6M | 0.11% | 74 |
|
|
2024
Q4 | $81.1M | Sell |
1,174,791
-35,396
| -3% | -$2.44M | 0.1% | 80 |
|
|
2024
Q3 | $88.3M | Sell |
1,210,187
-16,539
| -1% | -$1.21M | 0.12% | 75 |
|
|
2024
Q2 | $82.2M | Sell |
1,226,726
-265,068
| -18% | -$17.8M | 0.11% | 72 |
|
|
2024
Q1 | $40.5M | Sell |
1,491,794
-839,711
| -36% | -$22.8M | 0.06% | 158 |
|
|
2023
Q4 | $72.3M | Sell |
2,331,505
-51,534
| -2% | -$1.6M | 0.11% | 86 |
|
|
2023
Q3 | $60.2M | Buy |
2,383,039
+769,443
| +48% | +$19.4M | 0.1% | 94 |
|
|
2023
Q2 | $34M | Sell |
1,613,596
-14,922
| -0.9% | -$315K | 0.05% | 170 |
|
|
2023
Q1 | $27.8M | Buy |
1,628,518
+401,418
| +33% | +$6.84M | 0.05% | 188 |
|
|
2022
Q4 | $24.5M | Sell |
1,227,100
-29,357
| -2% | -$587K | 0.05% | 200 |
|
|
2022
Q3 | $27.1M | Sell |
1,256,457
-15,165
| -1% | -$327K | 0.05% | 178 |
|
|
2022
Q2 | $25.1M | Sell |
1,271,622
-6,471
| -0.5% | -$128K | 0.05% | 201 |
|
|
2022
Q1 | $30M | Sell |
1,278,093
-24,417
| -2% | -$574K | 0.04% | 230 |
|
|
2021
Q4 | $35.5M | Buy |
1,302,510
+67,849
| +5% | +$1.85M | 0.04% | 230 |
|
|
2021
Q3 | $34M | Buy |
1,234,661
+459,411
| +59% | +$12.7M | 0.04% | 228 |
|
|
2021
Q2 | $22.1M | Sell |
775,250
-15,682
| -2% | -$446K | 0.03% | 291 |
|
|
2021
Q1 | $26.9M | Sell |
790,932
-3,215
| -0.4% | -$110K | 0.03% | 252 |
|
|
2020
Q4 | $26.4M | Buy |
+794,147
| New | +$26.4M | 0.03% | 228 |
|